Speaker Profile
M.D., Vice President, Clinical Development; Head of Early Development, Kite
Biography
Scott Jung focuses on advancing engineered T-cell therapies from early clinical development toward potential patient use. His work spans CAR T-cell and T-cell receptor therapies for blood cancers and solid tumors, including clinical studies of KITE-363, KITE-753, KITE-222 and KITE-439. He brings experience in clinical trial strategy, study design and evidence generation, with particular interest in how single-arm trials, surrogate endpoints and real-world data can support development decisions. He also contributes to the International Society for Cell & Gene Therapy’s Clinical Translation Committee.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
